These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

711 related items for PubMed ID: 9669383

  • 21. Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients.
    Nyberg S, Eriksson B, Oxenstierna G, Halldin C, Farde L.
    Am J Psychiatry; 1999 Jun; 156(6):869-75. PubMed ID: 10360125
    [Abstract] [Full Text] [Related]

  • 22. Individual variation in D2 dopamine receptor occupancy in clozapine-treated patients.
    Pickar D, Su TP, Weinberger DR, Coppola R, Malhotra AK, Knable MB, Lee KS, Gorey J, Bartko JJ, Breier A, Hsiao J.
    Am J Psychiatry; 1996 Dec; 153(12):1571-8. PubMed ID: 8942453
    [Abstract] [Full Text] [Related]

  • 23. Prolactin plasma levels and D2-dopamine receptor occupancy measured with IBZM-SPECT.
    Schlegel S, Schlösser R, Hiemke C, Nickel O, Bockisch A, Hahn K.
    Psychopharmacology (Berl); 1996 Apr; 124(3):285-7. PubMed ID: 8740053
    [Abstract] [Full Text] [Related]

  • 24. D2 receptor occupancy during high- and low-dose therapy with the atypical antipsychotic amisulpride: a 123I-iodobenzamide SPECT study.
    la Fougère C, Meisenzahl E, Schmitt G, Stauss J, Frodl T, Tatsch K, Hahn K, Möller HJ, Dresel S.
    J Nucl Med; 2005 Jun; 46(6):1028-33. PubMed ID: 15937316
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of dopamine D-2 receptor occupancy by clozapine, risperidone, and haloperidol in vivo in the rodent and nonhuman primate brain using 18F-fallypride.
    Mukherjee J, Christian BT, Narayanan TK, Shi B, Mantil J.
    Neuropsychopharmacology; 2001 Oct; 25(4):476-88. PubMed ID: 11557161
    [Abstract] [Full Text] [Related]

  • 26. Occupancy of dopamine D2 receptors by the atypical antipsychotic drugs risperidone and olanzapine: theoretical implications.
    Frankle WG, Gil R, Hackett E, Mawlawi O, Zea-Ponce Y, Zhu Z, Kochan LD, Cangiano C, Slifstein M, Gorman JM, Laruelle M, Abi-Dargham A.
    Psychopharmacology (Berl); 2004 Oct; 175(4):473-80. PubMed ID: 15083259
    [Abstract] [Full Text] [Related]

  • 27. Imaging of dopamine receptors with [123I]iodobenzamide single-photon emission-computed tomography in neuroleptic malignant syndrome.
    Jauss M, Krack P, Franz M, Klett R, Bauer R, Gallhofer B, Dorndorf W.
    Mov Disord; 1996 Nov; 11(6):726-8. PubMed ID: 8914102
    [Abstract] [Full Text] [Related]

  • 28. Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine--a 123I IBZM single photon emission tomography (SPET) study.
    Pilowsky LS, Busatto GF, Taylor M, Costa DC, Sharma T, Sigmundsson T, Ell PJ, Nohria V, Kerwin RW.
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):148-53. PubMed ID: 8935810
    [Abstract] [Full Text] [Related]

  • 29. The role of striatal dopamine D2 receptors in the occurrence of extrapyramidal side effects: iodine-123-iodobenzamide single photon emission computed tomography study.
    Corripio I, Ferreira A, Portella MJ, Pérez V, Escartí MJ, Del Valle Camacho M, Sauras RB, Alonso A, Grasa EM, Carrió I, Catafau AM, Alvarez E.
    Psychiatry Res; 2012 Jan 30; 201(1):73-7. PubMed ID: 22281201
    [Abstract] [Full Text] [Related]

  • 30. Continuous intravenous infusion of iodine-123-IBZM for SPECT determination of human brain dopamine receptor occupancy by antipsychotic agent RWJ-37796.
    Seibyl JP, Zea-Ponce Y, Brenner L, Baldwin RM, Krystal JH, Offord SJ, Mochoviak S, Charney DS, Hoffer PB, Innis RB.
    J Nucl Med; 1996 Jan 30; 37(1):11-5. PubMed ID: 8543979
    [Abstract] [Full Text] [Related]

  • 31. Striatal dopaminergic D2 receptor occupancy and clinical efficacy in psychosis exacerbation: a 123I-IBZM study with ziprasidone and haloperidol.
    Corripio I, Catafau AM, Perez V, Puigdemont D, Mena E, Aguilar Y, Carrió I, Alvarez E.
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan 30; 29(1):91-6. PubMed ID: 15610950
    [Abstract] [Full Text] [Related]

  • 32. Subjective experience and striatal dopamine D(2) receptor occupancy in patients with schizophrenia stabilized by olanzapine or risperidone.
    de Haan L, Lavalaye J, Linszen D, Dingemans PM, Booij J.
    Am J Psychiatry; 2000 Jun 30; 157(6):1019-20. PubMed ID: 10831489
    [Abstract] [Full Text] [Related]

  • 33. [Diminution of hand writing area and D2-dopamine receptor blockade. Results from treatment with typical and atypical neuroleptics].
    Künstler U, Hohdorf K, Regenthal R, Seese A, Gertz HJ.
    Nervenarzt; 2000 May 30; 71(5):373-9. PubMed ID: 10846712
    [Abstract] [Full Text] [Related]

  • 34. In vivo measurement of haloperidol affinity to dopamine D2/D3 receptors by [123I]IBZM and single photon emission computed tomography.
    Videbaek C, Toska K, Friberg L, Holm S, Angelo HR, Knudsen GM.
    J Cereb Blood Flow Metab; 2001 Jan 30; 21(1):92-7. PubMed ID: 11149673
    [Abstract] [Full Text] [Related]

  • 35. D2-dopamine receptor occupancy differs between patients with and without extrapyramidal side effects.
    Scherer J, Tatsch K, Schwarz J, Oertel WH, Konjarczyk M, Albus M.
    Acta Psychiatr Scand; 1994 Oct 30; 90(4):266-8. PubMed ID: 7831996
    [Abstract] [Full Text] [Related]

  • 36. Striatal D2/D3 receptor occupancy, clinical response and side effects with amisulpride: an iodine-123-iodobenzamide SPET study.
    Meisenzahl EM, Schmitt G, Gründer G, Dresel S, Frodl T, la Fougère C, Scheuerecker J, Schwarz M, Boerner R, Stauss J, Hahn K, Möller HJ.
    Pharmacopsychiatry; 2008 Sep 30; 41(5):169-75. PubMed ID: 18763218
    [Abstract] [Full Text] [Related]

  • 37. Positive correlation between reduction of handwriting area and D2 dopamine receptor occupancy during treatment with neuroleptic drugs.
    Kuenstler U, Juhnhold U, Knapp WH, Gertz HJ.
    Psychiatry Res; 1999 Feb 22; 90(1):31-9. PubMed ID: 10320209
    [Abstract] [Full Text] [Related]

  • 38. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
    Kapur S, Zipursky RB, Remington G.
    Am J Psychiatry; 1999 Feb 22; 156(2):286-93. PubMed ID: 9989565
    [Abstract] [Full Text] [Related]

  • 39. Comparison between olanzapine and haloperidol on procedural learning and the relationship with striatal D2 receptor occupancy in schizophrenia.
    Paquet F, Soucy JP, Stip E, Lévesque M, Elie A, Bédard MA.
    J Neuropsychiatry Clin Neurosci; 2004 Feb 22; 16(1):47-56. PubMed ID: 14990759
    [Abstract] [Full Text] [Related]

  • 40. Optimizing limbic selective D2/D3 receptor occupancy by risperidone: a [123I]-epidepride SPET study.
    Bressan RA, Erlandsson K, Jones HM, Mulligan RS, Ell PJ, Pilowsky LS.
    J Clin Psychopharmacol; 2003 Feb 22; 23(1):5-14. PubMed ID: 12544369
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 36.